Strategic Capital Alternatives’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Strategic Capital Alternatives’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,715	Closed	-$132K	–	430
2015 Q2	$132K	Hold	1,715	–	–	0.03%	218
2015 Q1	$131K	Buy	+1,715	New	+$126K	0.03%	192
2014 Q4	–	Sell	-630	Closed	-$40K	–	264
2014 Q3	$40K	Buy	+630	New	+$38.9K	0.01%	253

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Strategic Capital Alternatives's PJP Position: Q3 2015 in Review

Strategic Capital Alternatives sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2015, closing a stake of 1,715 shares — an estimated $132K sold.

Strategic Capital Alternatives first reported a position in PJP in Q3 2014 and held it in 3 quarters. The position peaked at $132K in Q2 2015. 106 funds tracked by Wall St. Rank hold PJP as of Q3 2015.

Strategic Capital Alternatives reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Strategic Capital Alternatives sold 1,715 Invesco Pharmaceuticals ETF shares in Q3 2015, an estimated $132K.
Strategic Capital Alternatives first reported a position in Invesco Pharmaceuticals ETF in Q3 2014 and held it in 3 quarters.
Strategic Capital Alternatives's Invesco Pharmaceuticals ETF position peaked at $132K in Q2 2015.
106 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.